CliffBio
small molecule

NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE

NOREPINEPHRINE BITARTRATE

Loss of exclusivityMarch 2041latest FDA-listed patent expiry
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameNOREPINEPHRINE BITARTRATE IN 5% DEXTROSE
Active ingredientNOREPINEPHRINE BITARTRATE
StrengthEQ 16MG BASE/250ML (EQ 64MCG BASE/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalNovember 2023
Marketing statusRX

Listed patents

PatentExpiresType
12097170March 2041product

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.